Jack Meehan analyst BARCLAYS

Currently out of the existing stock ratings of Jack Meehan, 54 are a BUY (48.65%), 40 are a HOLD (36.04%), 17 are a SELL (15.32%).

Jack Meehan

Work Performance Price Targets & Ratings Chart

Analyst Jack Meehan, currently employed at BARCLAYS, has had 92.73% of price targets met with an average potential upside of 28.15%, reached in 287 days on average.

Jack Meehan has documented 233 price targets and ratings displayed on 23 stocks. The coverage is on Consumer Cyclical, Healthcare sectors.

Most recent stock forecast was given on QGEN, Qiagen NV at 05-Oct-2026.

Wall Street Analyst Jack Meehan

Analyst best performing recommendations are on INMD.
The best stock recommendation documented was for INMD on 11/6/2019. The price target of $22.5 was fulfilled within 5 days with a profit of $3.07 (15.8%), with a performance score of 31.6.

Average potential price target upside

  • of $78.18 (9.78%) on MTD.
  • of $49.61 (17.73%) on BIO.
  • of $44.8 (15.99%) on ILMN.
HOLX MYGN PDD Pinduoduo A Agilent Technologies TMO DGX Quest Diagnostics ILMN QGEN Qiagen NV BIO INMD IQV IQVIA Holdings MTD WAT LH Laboratory of America Holdings BRKR GHDX ICLR PKI AA AVTR QDEL RVTY PRAH

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Sep-2025

$90

10 months 5 days ago
(12-Jan-2026)

1/5 (20%)

$23.67 (35.69%)

343

Buy Since 05-Jan-2026

$78

$1.99 (2.62%)

$78

10 months 12 days ago
(05-Jan-2026)

22/25 (88%)

$3.25 (4.35%)

178

Hold Since 28-Jul-2022

$76

$69

1 years 6 days ago
(11-Nov-2025)

8/13 (61.54%)

$1.4 (1.88%)

72

Buy Since 12-Oct-2022

$78

$70

1 years 25 days ago
(23-Oct-2025)

5/14 (35.71%)

$4.11 (5.56%)

90

Buy Since 27-Jun-2024

$76

$78

1 years 26 days ago
(22-Oct-2025)

2/4 (50%)

$2.07 (2.80%)

163

Show more analysts

Please expand the browser size to see the chart

Which stock is Jack Meehan most bullish on?

Potential upside of $4.9 has been obtained for QGEN (QIAGEN NV)

Which stock is Jack Meehan most reserved on?

Potential downside of -$50.48 has been obtained for LH (LABORATORY OF AMERICA HOLDINGS)

What Year was the first public recommendation made by Jack Meehan?

On 2015
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?